Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125977765 | 12597776 | 5 | F | 20160110 | 20160913 | 20160727 | 20160923 | EXP | IT-MINISAL02-367337 | IT-TEVA-679241ACC | TEVA | 81.94 | YR | F | Y | 0.00000 | 20160923 | MD | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125977765 | 12597776 | 1 | PS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MILLIGRAM DAILY; | U | U | 77056 | 40 | MG | TABLET | |||||
125977765 | 12597776 | 2 | SS | TRIATEC - 5 MG COMPRESSE - SANOFI S.P.A. | RAMIPRIL | 1 | Oral | 5 MILLIGRAM DAILY; | U | U | 0 | 5 | MG | TABLET | |||||
125977765 | 12597776 | 3 | SS | TRIPLIAM - 10 MG/2,5 MG/5 MG - COMPRESSE RIVESTITE CON FILM - LES LABO | AMLODIPINEINDAPAMIDEPERINDOPRIL | 1 | Oral | U | 0 | 17.5 | MG | TABLET | |||||||
125977765 | 12597776 | 4 | C | NORVASC - 5 MG COMPRESSE | 2 | U | 0 | TABLET | |||||||||||
125977765 | 12597776 | 5 | C | ASCRIPTIN | ASPIRIN | 1 | U | 0 | |||||||||||
125977765 | 12597776 | 6 | C | ATORVASTATINA ABC - 80 MG COMPRESSE RIVESTITE CON FILM | 2 | U | 0 | FILM-COATED TABLET | |||||||||||
125977765 | 12597776 | 7 | C | NORMIX | RIFAXIMIN | 1 | U | 0 | |||||||||||
125977765 | 12597776 | 8 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | U | 0 | |||||||||||
125977765 | 12597776 | 9 | C | LENTOKALIUM | 2 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125977765 | 12597776 | 1 | Antacid therapy |
125977765 | 12597776 | 2 | Essential hypertension |
125977765 | 12597776 | 3 | Essential hypertension |
125977765 | 12597776 | 4 | Product used for unknown indication |
125977765 | 12597776 | 5 | Product used for unknown indication |
125977765 | 12597776 | 6 | Product used for unknown indication |
125977765 | 12597776 | 7 | Product used for unknown indication |
125977765 | 12597776 | 8 | Product used for unknown indication |
125977765 | 12597776 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125977765 | 12597776 | OT |
125977765 | 12597776 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125977765 | 12597776 | Confusional state | |
125977765 | 12597776 | Diarrhoea | |
125977765 | 12597776 | Hypokalaemia | |
125977765 | 12597776 | Hyponatraemia | |
125977765 | 12597776 | Nausea | |
125977765 | 12597776 | Vomiting | |
125977765 | 12597776 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125977765 | 12597776 | 1 | 20150101 | 20160110 | 0 | |
125977765 | 12597776 | 2 | 20150101 | 20160110 | 0 | |
125977765 | 12597776 | 3 | 20150101 | 20160110 | 0 |